BACKGROUND: Interference between pacemaker (PM) lead and tricuspid apparatus may cause tricuspid regurgitation (TR). However, data regarding TR in patients with implanted PM are controversial. Our aim is to find out the degree of TR in a group of patients before and following PM implantation in a prospective manner. METHODS: The study group consisted of the patients referred for implantation of permanent PM or implantable cardioverter defibrillator (ICD). All patients underwent two-dimensional and Doppler echocardiographic evaluation before and after device implantation. The severity of TR was qualitatively classified into four groups as normal or trivial, mild, moderate, or severe. All studies were reviewed for accuracy by a second independent interpreter. RESULTS: Sixty-one patients (mean age 53 +/- 8 years, 44 male) referred for PM (n = 55) or ICD (n = 6) implantation consisted of the study population. Echocardiographic degree of TR was mild in 21 (70%), moderate in 7 (23%) and severe in 2 (7%) patients before PM implantation. Following device implantation, mild TR was noted in 23 (76%), moderate in 10 (33%), and severe in 2 (6%) cases. After the procedure, the TR severity was increased from normal/trivial to mild in 5 (16%) cases and from mild to moderate in 3 (10%). There was no worsening of the severity of TR in patients with moderate regurgitation following device implantation. The severity of TR did not change at a mean follow-up of 6 +/- 3 months. CONCLUSIONS: New or worsening TR is relatively rare after PM implantation. It is not associated with an acute worsening or clinical deterioration. But echocardiographic follow-up is recommended to monitor other complications in chronic phase.
BACKGROUND: Interference between pacemaker (PM) lead and tricuspid apparatus may cause tricuspid regurgitation (TR). However, data regarding TR in patients with implanted PM are controversial. Our aim is to find out the degree of TR in a group of patients before and following PM implantation in a prospective manner. METHODS: The study group consisted of the patients referred for implantation of permanent PM or implantable cardioverter defibrillator (ICD). All patients underwent two-dimensional and Doppler echocardiographic evaluation before and after device implantation. The severity of TR was qualitatively classified into four groups as normal or trivial, mild, moderate, or severe. All studies were reviewed for accuracy by a second independent interpreter. RESULTS: Sixty-one patients (mean age 53 +/- 8 years, 44 male) referred for PM (n = 55) or ICD (n = 6) implantation consisted of the study population. Echocardiographic degree of TR was mild in 21 (70%), moderate in 7 (23%) and severe in 2 (7%) patients before PM implantation. Following device implantation, mild TR was noted in 23 (76%), moderate in 10 (33%), and severe in 2 (6%) cases. After the procedure, the TR severity was increased from normal/trivial to mild in 5 (16%) cases and from mild to moderate in 3 (10%). There was no worsening of the severity of TR in patients with moderate regurgitation following device implantation. The severity of TR did not change at a mean follow-up of 6 +/- 3 months. CONCLUSIONS: New or worsening TR is relatively rare after PM implantation. It is not associated with an acute worsening or clinical deterioration. But echocardiographic follow-up is recommended to monitor other complications in chronic phase.
Authors: Giselle A Baquero; Pradeep Yadav; Joshua B Skibba; Javier E Banchs; Latoya N Linton-Frazier; Eugene J Lengerich; Soraya M Samii; Erica Penny-Peterson; Deborah L Wolbrette; Jerry C Luck; Gerald V Naccarelli; Mario D Gonzalez Journal: J Interv Card Electrophysiol Date: 2013-12 Impact factor: 1.900
Authors: Karima Addetia; Francesco Maffessanti; Anuj Mediratta; Megan Yamat; Lynn Weinert; Joshua D Moss; Hemal M Nayak; Martin C Burke; Amit R Patel; Eric Kruse; Valluvan Jeevanandam; Victor Mor-Avi; Roberto M Lang Journal: J Am Soc Echocardiogr Date: 2014-08-14 Impact factor: 5.251
Authors: Daniel P Rothschild; James A Goldstein; Nathan Kerner; Amr E Abbas; Meet Patel; Wai Shun Wong Journal: J Interv Card Electrophysiol Date: 2017-07-06 Impact factor: 1.900
Authors: Francesca N Delling; Zena K Hassan; Gail Piatkowski; Connie W Tsao; Alefiyah Rajabali; Lawrence J Markson; Peter J Zimetbaum; Warren J Manning; James D Chang; Kenneth J Mukamal Journal: Am J Cardiol Date: 2016-01-06 Impact factor: 2.778
Authors: Masoud Sadreddini; Michelle J Haroun; Lisanne Buikema; Carlos Morillo; Sebastian Ribas; Syamkumar Divakaramenon; Stuart J Connolly; Robby Nieuwlaat; Eva M Lonn; Jeff S Healey; Hisham Dokainish Journal: Open Cardiovasc Med J Date: 2014-12-31
Authors: Mehmet Çakıcı; Evren Özçınar; Çağdaş Baran; Fatih Gümüş; Mustafa Serkan Durdu; Mustafa Bahadır İnan; Sadık Eryılmaz; Ahmet Rüçhan Akar Journal: Turk Gogus Kalp Damar Cerrahisi Derg Date: 2018-04-30 Impact factor: 0.332